» Home


INTAC® formulation technology protects intended drug action.

Grünenthal's tamper-resistant formulation technology (TRF) INTAC® is an innovative approach which can significantly raise the hurdles against abuse of prescription drugs by routes of administration which require the product first to be crushed (chewing, snorting, injecting). Grünenthal's proprietary INTAC® technology is featured in FDA-approved products, and the multi-national pharmaceutical company headquartered in Germany considers its INTAC® to be the leading technology for abuse-deterrent and tamper-resistant products.


The benefits of INTAC®